yohimbine has been researched along with Acute Kidney Failure in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Hayashi, K; Shimokawa, T; Tomita, S; Yamagata, M; Yoneda, K | 1 |
Miura, T; Nishinaka, T; Shimokawa, T; Takama, M; Terada, T; Tsutsui, H; Yamagata, M; Yukimura, T | 1 |
Miura, T; Nishinaka, T; Shimokawa, T; Takama, M; Tanba, T; Terada, T; Tojo, A; Tsutsui, H; Yamagata, M; Yoshida, S; Yukimura, T | 1 |
Aronson, P; Sandler, B | 1 |
Braunstein, G; Coody, GL; Favreau, JT; Fong, TL; Love, LA; Orshansky, G; Park, SS; Ryu, ML | 1 |
6 other study(ies) available for yohimbine and Acute Kidney Failure
Article | Year |
---|---|
Yohimbine ameliorates lipopolysaccharide-induced acute kidney injury in rats.
Topics: Active Transport, Cell Nucleus; Acute Kidney Injury; Animals; Cell Nucleus; Cyclic AMP Response Element-Binding Protein; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Enzymologic; Lipopolysaccharides; Male; NF-kappa B; Nitric Oxide Synthase Type II; Phosphorylation; Rats; Rats, Sprague-Dawley; Yohimbine | 2020 |
Inhibition of α2C-adrenoceptors ameliorates cisplatin-induced acute renal failure in rats.
Topics: Acridines; Acute Kidney Injury; Adrenergic alpha-2 Receptor Antagonists; Animals; Apoptosis; Chemokine CCL2; Cisplatin; Disease Models, Animal; Injections, Intraperitoneal; Kidney; Male; Norepinephrine; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Tumor Necrosis Factor-alpha; Yohimbine | 2018 |
Renoprotective effect of yohimbine on ischaemia/reperfusion-induced acute kidney injury through α2C-adrenoceptors in rats.
Topics: Acridines; Acute Kidney Injury; Adrenergic alpha-2 Receptor Antagonists; Animals; Chemokine CCL2; Cytoprotection; Gene Expression Regulation; Kidney; Male; Norepinephrine; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Reperfusion Injury; Tumor Necrosis Factor-alpha; Yohimbine | 2016 |
Yohimbine-induced cutaneous drug eruption, progressive renal failure, and lupus-like syndrome.
Topics: Acute Kidney Injury; Adult; Drug Eruptions; Erectile Dysfunction; Humans; Lupus Erythematosus, Systemic; Male; Yohimbine | 1993 |
Severe hepatotoxicity associated with the dietary supplement LipoKinetix.
Topics: Acute Kidney Injury; Adult; Adverse Drug Reaction Reporting Systems; Benzofurans; Benzopyrans; Caffeine; Chemical and Drug Induced Liver Injury; Dietary Supplements; Diiodothyronines; Drug Approval; Drug Combinations; Female; Humans; Male; Phenylpropanolamine; United States; United States Food and Drug Administration; Yohimbine | 2002 |
Summary for patients. Liver failure associated with the dietary supplement LipoKinetix.
Topics: Acute Kidney Injury; Adult; Adverse Drug Reaction Reporting Systems; Benzofurans; Benzopyrans; Caffeine; Chemical and Drug Induced Liver Injury; Dietary Supplements; Diiodothyronines; Drug Approval; Drug Combinations; Female; Humans; Male; Phenylpropanolamine; United States; United States Food and Drug Administration; Yohimbine | 2002 |